Lack of effects of the TNF-α and IL-10 gene polymorphisms in Mexican patients with lepromatous leprosy

Leprosy Review

Volumn 83, Issue 1, 2012, Pages 34-39

  Félix, Jesús Salvador Velarde ^a,b   Cázarez Salazar, Silvestre ^a   Ríos Tostado, Juan José ^a,b   Flores Garcia, Aurelio ^c   Rangel Villalobos, Héctor ^d   Murillo Llanes, Joel ^a  

^a Servicios de Salud de Sinaloa   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE SINALOA   (Mexico)

^c UNIVERSIDAD AUTÓNOMA DE NAYARIT   (Mexico)

^d UNIVERSITY OF GUADALAJARA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DERMATOLOGICAL PROCEDURES; ETHNIC GROUP; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LEPROMATOUS LEPROSY; MAJOR CLINICAL STUDY; MALE; MEXICAN MESTIZO; MEXICO; MULTIBACILLARY LEPROSY; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SLIT SKIN SMEAR EXAMINATION;

ADULT; ALLELES; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HUMANS; INTERLEUKIN-10; LEPROSY, LEPROMATOUS; MALE; MEXICO; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POPULATION GROUPS; PROMOTER REGIONS, GENETIC; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84859336844     PISSN: 03057518     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Yamamura M, Uyemura K, Deans RJ et al. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science, 1991; 254: 277-279.
2. Moraes MO, Pacheco AG, Schonkeren JJ et al. Interleukin-10 promoter single-nucleotide polymorphisms as markers for disease susceptibility and disease severity in leprosy. Genes Immun, 2004; 5: 592-595.
3. Huang Y, Krein PM, Muruve DA et al. Complement factor B gene regulation synergistic effects of TNF-αlpha and IFN-gamma in macrophages. J Immunol, 2002; 169: 2627-2635.
4. Kindler V, Sappino AP, Grau GE et al. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell, 1989; 56: 731-740.
5. Bermudez LE, Young LS. Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex. J Immunol, 1988; 140: 3006-3013.
6. Selmaj KW, Raine CS. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol, 1988; 23: 339-346.
7. Rook GA, Attiyab RA, Foley N. The role of cytokines in the immunopathology of tuberculosis, and the regulation of agalactosyl IgG. Lymphokine Res, 1989; 8: 323-328.
8. Cardoso CC, Pereira AC, de Sales Marques C et al. Leprosy susceptibility: genetic variations regulate innate and adaptive immunity, and disease outcome. Future Microbiol, 2011; 6: 533-549.
9. McGuire W, Hill AV, Allsopp CE. Variation in the TNF-αlpha promoter region associated with susceptibility to cerebral malaria. Nature, 1994; 371: 508-510.
10. Cabrera M, Shaw MA, Sharples C et al. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med, 1995; 182: 1259-1264.
11. Caballero A, Bravo MJ, Nieto A et al. TNFA promoter polymorphism and susceptibility to brucellosis. Clin Exp Immunol, 2000; 121: 480-483.
12. Nadel S, Newport MJ, Booy R et al. Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease. J Infect Dis, 1996; 174: 878-880.
13. Lio D, Caruso C, Di Stefano R et al. IL-10 and TNF-αlpha polymorphisms and the recovery from HCV infection. Hum Immunol, 2003; 64: 674-680.
14. Oztuzcu S, Cakmak EA, Sivasli E et al. Gene Expression and Promoter Region Polymorphisms of Interleukin-10 in Meningitis Patients. Genet Test Mol Biomarkers, 2011; 15: 327-331.
15. Mitsani D, Nguyen MH, Girnita DM et al. A polymorphism linked to elevated levels of interferon-g is associated with an increased risk of cytomegalovirus disease among Caucasian lung transplant recipients at a single center. J Heart Lung Transplant, 2011; 30: 523-529.
16. Roy S, McGuire W, Mascie-Taylor CG et al. Tumor necrosis factor promoter polymorphism and susceptibility to lepromatous leprosy. J Infect Dis, 1997; 176: 530-532.
17. Santos AR, Almeida AS, Suffys PN et al. Tumor necrosis factor promoter polymorphism (TNF2) seemed to protect against development of severe forms of leprosy in a pilot study in Brazilian patients. Int J Lepr Other Mycobact Dis, 2000; 68: 325-327.
18. Fitness J, Floyd S, Warndorff DK et al. Large-scale candidate gene study of leprosy susceptibility in the Karonga district of northern Malawi. Am J Trop Med Hyg, 2004; 71: 330-340.
19. Pereira AC, Brito-de-Souza VN, Cardoso CC et al. Genetic, epidemiological and biological analysis of interleukin-10 promoter single-nucleotide polymorphisms suggests a definitive role for -819C/T in leprosy susceptibility. Genes Immun, 2009; 10: 174-180.
20. Franceschi DS, Mazini PS, Rudnick CC et al. Influence of TNF and IL10 gene polymorphisms in the immunopathogenesis of leprosy in the south of Brazil. Int J Infect Dis, 2009; 13: 493-498.
21. Ridley DS, Jopling W. Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis, 1966; 34: 255-273.
22. Gustincich S, Manfioletti G, Del Sal G et al. A fast method for high-quality genomic DNA extraction from whole human blood. Biotechniques, 1991; 11: 298-302.
23. Edwards-Smith CJ, Jonsson JR, Purdie DM et al. Interleukin-10 Promoter Polymorphism Predicts Initial Response of Chronic Hepatitis C to Interferon Alfa. Hepatology, 1999; 30: 526-530.
24. Gibson AW, Edberg JC, Wu J et al. Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J Immunol, 2001; 166: 3915-3922.
25. Santos AR, Suffys PN, Vanderborght PR et al. Role of tumor necrosis factor-alpha and interleukin-10 promoter gene polymorphisms in leprosy. J Infect Dis, 2002; 186: 1687-1691.
26. Price AL, Zaitlen NA, Reich D et al. New approaches to population stratification in genome-wide association studies. Nat Rev Genet, 2010; 11: 459-463.
27. Bryc K, Velez C, Karafet T et al. Genome-wide patterns of population structure and admixture among Hispanic/Latino populations. Proc Natl Acad Sci, 2010; 107: 8954-8961.
28. Silva-Zolezzi I, Hidalgo-Miranda A, Estrada-Gil J et al. Analysis of genomic diversity in Mexican Mestizo populations to develop genomic medicine in Mexico. Proc Natl Acad Sci, 2009; 106: 8611-8616.
29. Rubi-Castellanos R, Martínez-Cortés G, Muñoz-Valle JF et al. Pre-Hispanic Mesoamerican demography approximates the present-day ancestry of Mestizos throughout the territory of Mexico. Am J Phys Anthropol, 2009; 139: 284-294.
30. González-Enríquez GV, Rubio-Benítez MI, García-Gallegos V et al. Contribution of TNF-308A and CCL2-2518A to carotid intima-media thickness in obese mexican children and adolescents. Arch Med Res, 2008; 39: 753-759.
31. Rodríguez-Carreón AA, Zúñiga J, Hernández-Pacheco G et al. Tumor necrosis factor-alpha -308 promoter polymorphism contributes independently to HLA alleles in the severity of rheumatoid arthritis in Mexicans. J Autoimmun, 2005; 24: 63-68.
32. Alvarado-Navarro A, Montoya-Buelna M, Muñoz-Valle JF et al. The 30UTR 1188 A/C polymorphism in the interleukin-12p40 gene (IL-12B) is associated with lepromatous leprosy in the west of Mexico. Immunol Lett, 2008; 118: 148-151.
33. Velarde-Felix JS, Rendón-Maldonado JG, Ochoa Ramírez LA et al. Lack of association between 30 UTR 1188 A/C polymorphism in the IL- 12p40 gene and lepromatous leprosy in Sinaloa, México. Int J Dermatol, 2011; Apr 6. doi: 10.1111/j.1365-4632.2010.04597.